The Weight Loss Atlas · Pipeline tracker

Every weight-loss drug in late-stage trials, and what happens next

Follow each medicine from Phase 2 to the FDA. Every date shows where it comes from: a company statement or the ClinicalTrials.gov registry. For what each stage means, see why promising weight-loss drugs don't always reach the pharmacy.

Registry primary completionLast registered completionFilingFDA decisionResult reportedTrial start

Registry dates are the "primary completion" a sponsor enters on ClinicalTrials.gov: when data collection for the main outcome is due to end. Results usually come weeks to months later, and sponsors revise these dates. Treat them as a schedule, not a promise. A medicine in a trial is not approved and is not available to buy. Source: ClinicalTrials.gov, pulled Nov 7, 2026, plus the company statements linked on each item. Counts cover active Phase 2 and Phase 3 trials with an obesity or overweight condition.